by Jeyanthi Kunadhasan | Dec 20, 2022 | C19 (COVID-19), VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS)
Motivation The Pfizer mRNA “vaccine” trial 2-month data report “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine”, claimed 95% EFFICACY on the basis of RRR (relative risk reduction) in only 170 trial participants out of the total of...
